COL1A2 and cardiomyopathy: Given the baseline cardiomyopathy and augmented fibrosis observed in germline Col1a2 gene-deleted mice, we then employed a conditional Col1a2 deletion strategy to investigate the acute effects of fibrosis inhibition within the heart during disease stimulation.